Allianz Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.6M Buy
88,200
+16,500
+23% +$3.84M 0.02% 597
2025
Q4
$14.8M Buy
71,700
+7,300
+11% +$1.44M 0.02% 717
2025
Q3
$11.9M Sell
64,400
-22,300
-26% -$3.82M 0.01% 771
2025
Q2
$13.2M Buy
86,700
+5,500
+7% +$845K 0.02% 712
2025
Q1
$13.5M Buy
81,200
+28,200
+53% +$4.41M 0.02% 705
2024
Q4
$7.66M Buy
53,000
+16,800
+46% +$2.6M 0.01% 848
2024
Q3
$5.87M Sell
36,200
-5,900
-14% -$940K 0.01% 965
2024
Q2
$6.15M Buy
42,100
+28,400
+207% +$4.22M 0.01% 869
2024
Q1
$2.17M Sell
13,700
-46,000
-77% -$7.32M ﹤0.01% 1155
2023
Q4
$9.36M Sell
59,700
-101,900
-63% -$15.6M 0.02% 702
2023
Q3
$25.2M Buy
161,600
+83,600
+107% +$13.8M 0.04% 416
2023
Q2
$12.9M Sell
78,000
-48,900
-39% -$7.89M 0.02% 581
2023
Q1
$19.7M Buy
126,900
+80,700
+175% +$13M 0.03% 485
2022
Q4
$8.16M Sell
46,200
-31,500
-41% -$5.44M 0.02% 744
2022
Q3
$12.7M Buy
77,700
+46,500
+149% +$7.87M 0.03% 586
2022
Q2
$5.54M Sell
31,200
-6,500
-17% -$1.16M 0.01% 1064
2022
Q1
$6.68M Buy
37,700
+18,300
+94% +$3.11M 0.01% 1127
2021
Q4
$3.32M Sell
19,400
-136,700
-88% -$22.4M ﹤0.01% 1400
2021
Q3
$25.2M Buy
156,100
+123,500
+379% +$21.1M 0.02% 640
2021
Q2
$5.37M Buy
+32,600
New +$5.4M ﹤0.01% 1081
2020
Q3
Sell
-166,000
Closed -$23.3M 2138
2020
Q2
$23.3M Sell
166,000
-67,900
-29% -$9.89M 0.03% 563
2020
Q1
$30.7M Sell
233,900
-215,000
-48% -$30.5M 0.04% 420
2019
Q4
$65.5M Sell
448,900
-59,900
-12% -$8.12M 0.06% 358
2019
Q3
$65.8M Buy
508,800
+222,700
+78% +$29.3M 0.06% 345
2019
Q2
$39.8M Buy
286,100
+42,400
+17% +$5.87M 0.04% 510
2019
Q1
$34.1M Sell
243,700
-80,000
-25% -$10.7M 0.03% 531
2018
Q4
$41.8M Sell
323,700
-142,500
-31% -$19.9M 0.05% 418
2018
Q3
$64.4M Sell
466,200
-88,600
-16% -$11.8M 0.06% 357
2018
Q2
$67.3M Buy
554,800
+303,700
+121% +$37.9M 0.07% 317
2018
Q1
$32.2M Sell
251,100
-86,100
-26% -$11.6M 0.03% 619
2017
Q4
$47.1M Sell
337,200
-525,100
-61% -$73.1M 0.04% 562
2017
Q3
$112M Buy
862,300
+171,300
+25% +$22.7M 0.1% 248
2017
Q2
$91.4M Buy
691,000
+46,400
+7% +$5.92M 0.09% 268
2017
Q1
$80.3M Sell
644,600
-2,300
-0.4% -$275K 0.08% 298
2016
Q4
$74.5M Buy
646,900
+58,000
+10% +$6.7M 0.07% 370
2016
Q3
$69.6M Buy
588,900
+258,100
+78% +$31.3M 0.07% 310
2016
Q2
$40.1M Buy
330,800
+161,700
+96% +$18.4M 0.04% 525
2016
Q1
$18.3M Buy
169,100
+49,900
+42% +$5.17M 0.02% 828
2015
Q4
$12.2M Buy
119,200
+83,000
+229% +$8.35M 0.01% 973
2015
Q3
$3.38M Sell
36,200
-129,800
-78% -$12.6M ﹤0.01% 1429
2015
Q2
$16.2M Buy
166,000
+60,500
+57% +$6.06M 0.02% 887
2015
Q1
$10.6M Sell
105,500
-3,500
-3% -$356K 0.01% 934
2014
Q4
$11.4M Buy
109,000
+75,200
+222% +$7.92M 0.01% 909
2014
Q3
$3.6M Buy
33,800
+30,800
+1,027% +$3.19M ﹤0.01% 1214
2014
Q2
$314K Buy
+3,000
New +$303K ﹤0.01% 1699

Other funds holding JNJ

Allianz Asset Management's JNJ Position: Q1 2026 in Review

Allianz Asset Management reduced its Johnson & Johnson (JNJ) stake by 5.5% in Q1 2026, selling an estimated $76.6M and leaving 5,690,502 shares worth $1.39B. The position accounts for 1.46% of the portfolio, ranked #8.

Allianz Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Allianz Asset Management held 5,690,502 shares of Johnson & Johnson worth $1.39B as of Q1 2026.
  • Allianz Asset Management sold 328,726 Johnson & Johnson shares in Q1 2026, an estimated $76.6M.
  • Johnson & Johnson made up 1.46% of Allianz Asset Management's portfolio in Q1 2026, its #8 holding.
  • Allianz Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.